BETA-MYRCENE
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
Mainterm | BETA-MYRCENE |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 123-35-3 |
Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 31253 |
IUPAC Name | 7-methyl-3-methylideneocta-1,6-diene |
InChI | InChI=1S/C10H16/c1-5-10(4)8-6-7-9(2)3/h5,7H,1,4,6,8H2,2-3H3 |
InChI Key | UAHWPYUMFXYFJY-UHFFFAOYSA-N |
Canonical SMILES | CC(=CCCC(=C)C=C)C |
Molecular Formula | C10H16 |
Wikipedia | myrcene |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 136.238 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 4 |
Complexity | 145.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G A A A A A A A D A C A A A A C A A A A A A C A A i B C A A A A A A A g A A A I C A A A A A g I A A I A A Q A A A A A A g A A I A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 0.0 |
Monoisotopic Mass | 136.125 |
Exact Mass | 136.125 |
XLogP3 | None |
XLogP3-AA | 4.3 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9478 |
Human Intestinal Absorption | HIA+ | 0.9538 |
Caco-2 Permeability | Caco2+ | 0.7228 |
P-glycoprotein Substrate | Non-substrate | 0.6521 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7010 |
Non-inhibitor | 0.8493 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8183 |
Distribution | ||
Subcellular localization | Nucleus | 0.5972 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8553 |
CYP450 2D6 Substrate | Non-substrate | 0.8223 |
CYP450 3A4 Substrate | Non-substrate | 0.5742 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7790 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9178 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9341 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8849 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9747 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7215 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8650 |
Non-inhibitor | 0.9292 | |
AMES Toxicity | Non AMES toxic | 0.9227 |
Carcinogens | Carcinogens | 0.5684 |
Fish Toxicity | High FHMT | 0.9448 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.5960 |
Honey Bee Toxicity | High HBT | 0.8407 |
Biodegradation | Ready biodegradable | 0.7708 |
Acute Oral Toxicity | III | 0.8030 |
Carcinogenicity (Three-class) | Non-required | 0.4589 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.4432 | LogS |
Caco-2 Permeability | 1.5571 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.4040 | LD50, mol/kg |
Fish Toxicity | 0.6786 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.6891 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | Dermal ; inhalation |
---|---|
Mechanism of Toxicity | Myrcene exhibits tyrosinase inhibitory activities, which plays an important role in neuromelanin formation . |
Metabolism | None |
Toxicity Values | LD50: >5000.00 mg/kg (Oral, Rat) LD50: >5000.00 mg/kg (Dermal, Rabbit) |
Lethal Dose | None |
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
Minimum Risk Level | None |
Health Effects | Health effects may include dermatitis (A334). |
Treatment | Monitor for respiratory distress in case of inhalation exposure. Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Administer symptomatic treatment as necessary. |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Prenol lipids |
Subclass | Monoterpenoids |
Intermediate Tree Nodes | Not available |
Direct Parent | Acyclic monoterpenoids |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Acyclic monoterpenoid - Branched unsaturated hydrocarbon - Alkatriene - Unsaturated aliphatic hydrocarbon - Unsaturated hydrocarbon - Olefin - Acyclic olefin - Hydrocarbon - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as acyclic monoterpenoids. These are monoterpenes that do not contain a cycle. |
From ClassyFire
Targets
- General Function:
- Protein homodimerization activity
- Specific Function:
- This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the rate-limiting conversions of tyrosine to DOPA, DOPA to DOPA-quinone and possibly 5,6-dihydroxyindole to indole-5,6 quinone.
- Gene Name:
- TYR
- Uniprot ID:
- P14679
- Molecular Weight:
- 60392.69 Da
References
- Matsuura R, Ukeda H, Sawamura M: Tyrosinase inhibitory activity of citrus essential oils. J Agric Food Chem. 2006 Mar 22;54(6):2309-13. [16536612 ]
From T3DB